Cancer Reports

SCIE

国际简称：Cancer Rep-Us 参考译名：癌症报告

主要研究方向：Medicine-Oncology 非预警期刊审稿周期：17 Weeks

《癌症报告》(Cancer Reports)是一本由Wiley出版的以Medicine-Oncology为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

4区中科院分区
Q3 JCR分区
322 年发文量
2.5 IF影响因子
未开放 是否OA
2018 创刊年份
Monthly 出版周期
English 出版语言

cancer Reports Is An International, Peer-reviewed, Open Access Journal Publishing Basic, Translational, Clinical And Interdisciplinary Research In Cancer Biology, Diagnosis, Treatment, Outcome, Supportive Care, Epidemiology And Health Disparities. The Journal Considers Data-driven, Scientifically Valid Findings Including Incremental Findings, Pilot Studies, Replication And Negative Findings. Cancer Reports Is A Wiley Open Access Journal, One Of A New Series Of Peer Reviewed Titles Publishing Quality Research With Speed And Efficiency.

[ 查看全部 ]

投稿咨询加急咨询

Cancer Reports期刊信息

ISSN：2573-8348
出版语言：English
是否OA：未开放
出版地区：United States
是否预警：否
出版商：Wiley
出版周期：Monthly
创刊时间：2018
开源占比：0.5731
Gold OA文章占比：100.00%
OA被引用占比：0.1392...
出版国人文章占比：0.04
出版撤稿占比：
研究类文章占比：86.65%

Cancer Reports CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

3.7

0.707

0.696

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q3	233 / 428	45%
大类：Medicine 小类：Cancer Research	Q3	165 / 233	29%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Cancer Reports中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	ONCOLOGY 肿瘤学	4区

Cancer Reports JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	ESCI	Q3	204 / 333	38.9
学科：ONCOLOGY	ESCI	Q4	260 / 333	22.07

Cancer Reports历年数据统计

影响因子

中科院分区

Cancer Reports中国学者发文选摘

1、Alpha-Fetoprotein Is a Potential Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC): A Case Repor
Author: Zhong, Kaiwen; Wu, Xiaoying; Lin, Xiangling; Xie, Maoyun; Deng, Min; Tao, Qiang; Qin, Wei; Peng, Songlin

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 4, pp. -. DOI: 10.1002/cnr2.70547
2、Application of Digital Medicine to the Diagnosis and Treatment of Head and Neck Tumor
Author: He, Bin; Hu, Yanghao; Wang, Zhikai; Tong, Yejingwen; Gan, Shengqi; Zhu, Yaojie; Wang, Chongyang; Ye, Dong

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 4, pp. -. DOI: 10.1002/cnr2.70556
3、Comprehensive Bioinformatic Analysis of TONSL Expression in Pan-Cance
Author: Yang, Ying; Zhou, Bolan

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 4, pp. -. DOI: 10.1002/cnr2.70551
4、NFIB Regulates Chemoresistance in Small Cell Lung Cancer by Suppressing Notch Signaling Activit
Author: Qin, Weixin; Wang, Ziyan; Deng, Shuzhe; Qiu, Huilei; Meng, Hongxue; Geng, Jingshu

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 4, pp. -. DOI: 10.1002/cnr2.70526
5、CHI3L1 Is Associated With TP53 Signaling and Promotes Papillary Thyroid Carcinoma Progressio
Author: Cai, Fen; Zhou, Ya'nan; Yang, Yeran; Zhang, Meng; Zhang, Xuan; Chang, Yan; Wang, Shengcai; Wu, Xinyuan; Guo, Yongli; Yu, Yongbo; Ni, Xin; Geng, Jiangqiao

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 4, pp. -. DOI: 10.1002/cnr2.70553
6、PRKD3 Overexpression May Improve Survival and Suppresses Proliferation in Colorectal Cance
Author: Zhang, Bin; Chang, Chen; Chen, Jingli; Cao, Yue; Chang, Yu; Liu, Lele; Li, Wensheng; Wang, Guorong

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 4, pp. -. DOI: 10.1002/cnr2.70543
7、Effect of First-Line Chemotherapy Alone Versus First-Line Chemotherapy Plus Radiotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer in the IMRT Era: A Retrospective Cohort Stud
Author: Liu, Zihao; Tian, Yaru; Ma, Ji; Meng, Dong-Fang

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 4, pp. -. DOI: 10.1002/cnr2.70531
8、Setup Error Differences and Margin Expansion Among Rectal Cancer Segments: Consistency Evaluation Between EPID and iSCOU
Author: Wan, Bao; Han, Jiangtao; Wu, Qian; Lu, Jingjing; Li, Xueshan; Zheng, Yongtai; Liu, Chao; Sun, Shuo; Zhao, Yu; Huan, Fukui; Li, Tantan

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 3, pp. -. DOI: 10.1002/cnr2.70515